Authors
Latest:
Barhemsys (Amisulpride) for Postoperative Nausea and VomitingOn February 27, 2020, the FDA approved an intravenous solution of amisulpride (Barhemsys; Acacia Pharma) to treat and prevent postoperative nausea and vomiting.
Latest:
COPD Exacerbations Reduced Substantially With Dupilumab, Phase 3 Data ShowsThe NOTUS trial was shown to have successfully achieved its primary endpoint, demonstrating the notable efficacy of dupilumab in reducing exacerbations by 34% versus placebo in individuals with moderate-to-severe COPD showing evidence of type 2 inflammation.
Latest:
A Surge in Mpox Cases Could Occur This SummerDemetre Daskalakis, MD, MPH, urged those in the LGBTQ+ community to get fully vaccinated against the disease.
Latest:
Closed-Loop Glucose Management Led to Direct, Indirect Benefits Among Youth With T1DBeyond improving glucose control, hybrid closed-loop glucose monitoring systems offered indirect benefits like reduced fear of hypoglycemia and improved sleep quality among youth with type 1 diabetes (T1D).
Latest:
Continuous Glucose Monitoring and Its Part in Diabetes ManagementContinuous glucose monitoring has many benefits and can improve disease management in for both diabetes types.
Latest:
How to Help Make Health Equity a RealityCMS and state officials are using payment incentives, data collection and program requirements to start edging the lofty ideals of health equity toward reality.
Latest:
Efficacy of Tapinarof Cream 1% Demonstrated in Atopic Dermatitis in Skin of ColorA lack of diversity in clinical trials has hampered health care providers from understanding the nuances of diseases across specific patient populations.
Latest:
Q&A: Statin, Nonstatin Combination Therapy to Treat Patients’ Cardiovascular Risk | ASHP MidyearJohn Bucheit, PharmD, joined Drug Topics to discuss statins and nonstatins’ efficacy in treating cardiovascular disease.
Latest:
Drug Review: Lebrikizumab-lbkz Demonstrates Improvement in Atopic DermatitisFDA approval was granted on September 13, 2024.
Latest:
Understanding the Foundations of Pharmacy Financial HealthPharmacy schools specialize in training students as experts in patient care—not as expert business owners.
Latest:
Mind-Body Resilience for Women: A Focus on DepressionDeveloping innovative solutions for women with depression, accounting for differences in gender and sex, are critically important
Latest:
FDA: Secukinumab Approved for Hidradenitis SuppurativaSecukinumab is the only anti IL-17A inhibitor approved for hidradenitis suppurativa.
Latest:
Expert Discusses McKesson's Approach to Supporting Community Pharmacies | McKesson ideaShareThrough platforms like Health Mart Atlas, the company is providing pharmacies with tools to better understand their financial landscape.
Latest:
Amplifying Technicians: Josie Quick, CPhT-Adv, CSPT, BUSIn this episode, host Taylor Watterson, PharmD, PhD, welcomes Josie Quick, CPhT-Adv, CSPT, BUS, an advanced certified pharmacy technician with over 20 years of experience.
Latest:
USDA provides conditional license for Canine Parvovirus Monoclonal AntibodyThe brand-new treatment from Elanco is currently the only approved therapeutic solution proven to treat canine parvovirus.
Latest:
Pharmacists as the Authority on Ultra-High-Cost DrugsErin Fox, PharmD, MHA, BCPS, FASHP, joined Drug Topics to discuss ultra-high-cost drugs and the American Society of Health-System Pharmacists 2025 Pharmacy Forecast.
Latest:
Scripted for Her: Understanding GriefThis episode explores the often-overlooked impact of grief on patients and pharmacy staff, highlighting the vital role pharmacists play in recognizing emotional health needs and providing compassionate support.
Latest:
What's Next in Development of RSV Vaccines for Children?How much progress have we made in developing therapies to treat this common childhood respiratory disorder?
Latest:
Asembia Does a Great Job Bringing Professionals Together, Experts Say | Asembia 2025The Summit provides a rare opportunity for professionals to dive deep into emerging healthcare technologies and treatment models.
Latest:
FDA Approves Drug Combo for Young Glioma PatientsA combination of dabrafenib with trametinib was approved by the FDA for treatment of pediatric patients 1 year and older with low-grade glioma & BRAF V600E mutation who require systemic therapy.
Latest:
Probiotics for the Prevention of Pediatric Antibiotic-Associated DiarrheaEvidence of the relationship between probiotics and antibiotics is lacking.
Latest:
Probiotics for the Prevention of Pediatric Antibiotic-Associated DiarrheaEvidence of the relationship between probiotics and antibiotics is lacking.
Latest:
How Pharmacy Matches Perfectly With NutritionKnown as “The Nutrition Pharmacist,” Sarah Gray, PharmD, GAICD, recently joined Drug Topics to discuss her dual profession within health care.
Latest:
Mind-Body Resilience for Women: A Focus on DepressionDeveloping innovative solutions for women with depression, accounting for differences in gender and sex, are critically important
Latest:
The Wait for RSV Vaccines ContinuesTwo RSV vaccines for seniors have completed phase 3 trials and demonstrated beneficial results. The public still awaits FDA decisions on potential approvals for both.
Latest:
Pharmacists Provide Relief After Natural DisastersPharmacists are indispensable members of the disaster relief team, playing a crucial role in ensuring the continuity of care during and after a natural disaster.
Latest:
Scripted for Her: Addressing Preconception Health Through MTMIn this episode, Natalie DiPietro Mager, PharmD, PhD speaks with David Bright, PharmD, MBA, professor at Ferris State University College of Pharmacy.
Latest:
Vericiguat (Verquvo) for Heart Failure With Reduced Ejection FractionA new drug review for vericiguat, indicated for heart failure, reports efficacy and safety data.
